ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings
Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 子公司管理制度（2025年11月） | 2025-11-25 | Chinese | |
| 关于回购注销部分限制性股票减资暨通知债权人的公告 | 2025-11-25 | Chinese | |
| 中国国际金融股份有限公司关于安徽安科生物工程（集团）股份有限公司第三期限制性股票激励计划相关事项之独立财务顾问报告 | 2025-11-25 | Chinese | |
| 独立董事候选人声明与承诺（汪律） | 2025-11-25 | Chinese | |
| 独立董事候选人声明与承诺（姚禄仕） | 2025-11-25 | Chinese | |
| 独立董事候选人声明与承诺（耿小平） | 2025-11-25 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 35333639 | 子公司管理制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333626 | 关于回购注销部分限制性股票减资暨通知债权人的公告 | 2025-11-25 | Chinese | ||
| 35333615 | 中国国际金融股份有限公司关于安徽安科生物工程（集团）股份有限公司第三期限制性股票激励计划相关事项之独立财务顾问报告 | 2025-11-25 | Chinese | ||
| 35333606 | 独立董事候选人声明与承诺（汪律） | 2025-11-25 | Chinese | ||
| 35333599 | 独立董事候选人声明与承诺（姚禄仕） | 2025-11-25 | Chinese | ||
| 35333590 | 独立董事候选人声明与承诺（耿小平） | 2025-11-25 | Chinese | ||
| 35333583 | 监事会关于公司第三期限制性股票激励计划相关事项的核查意见 | 2025-11-25 | Chinese | ||
| 35333576 | 关于第八届董事会第二十四次会议决议的公告 | 2025-11-25 | Chinese | ||
| 35333565 | 对外投资管理制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333553 | 薪酬与考核委员会工作细则（2025年11月） | 2025-11-25 | Chinese | ||
| 35333548 | 独立董事专门会议工作制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333539 | 对外提供财务资助管理制度（2025年11月） | 2025-11-25 | Chinese | ||
| 35333533 | 关于变更注册资本暨修订《公司章程》的公告 | 2025-11-25 | Chinese | ||
| 35333531 | 关于第八届监事会第二十二次会议决议的公告 | 2025-11-25 | Chinese | ||
| 35333522 | 独立董事任职及议事制度（2025年11月） | 2025-11-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55035/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55035 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55035 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55035 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55035}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. (id: 55035)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.